T.MAN Pharmaceutical PCL (BKK:TMAN) Beginning Cash Position: ฿562 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:TMAN T.MAN Pharmaceutical PCL BKK:TMAN
18 GF Score
Price ฿10.30
View Full Analysis

What is T.MAN Pharmaceutical PCL Beginning Cash Position?

T.MAN Pharmaceutical PCL BKK:TMAN +1.98% 18 Beginning Cash Position is ฿562 Mil as of Jun. 2026. GuruFocus rates BKK:TMAN with a GF Score™ of 18/100.

T.MAN Pharmaceutical PCL's Beginning Cash Position for the quarter that ended in Jun. 2026 was ฿562 Mil.

T.MAN Pharmaceutical PCL's quarterly Beginning Cash Position increased from Dec. 2025 (฿392 Mil) to Mar. 2026 (฿399 Mil) and increased from Mar. 2026 (฿399 Mil) to Jun. 2026 (฿562 Mil).

T.MAN Pharmaceutical PCL's annual Beginning Cash Position increased from Dec. 2023 (฿307 Mil) to Dec. 2024 (฿348 Mil) and increased from Dec. 2024 (฿348 Mil) to Dec. 2025 (฿348 Mil).

T.MAN Pharmaceutical PCL Beginning Cash Position Related Terms

T.MAN Pharmaceutical PCL Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for T.MAN Pharmaceutical PCL's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

T.MAN Pharmaceutical PCL Beginning Cash Position Chart

T.MAN Pharmaceutical PCL Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
22.19 307.17 348.04 348.39

T.MAN Pharmaceutical PCL Quarterly Data
Jun23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 425.09 545.80 392.02 399.31 562.06
BKK:TMAN
18GF Score
T.MAN Pharmaceutical PCL BKK:TMAN
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

T.MAN Pharmaceutical PCL Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of ฿562 Mil mean?
T.MAN Pharmaceutical PCL (BKK:TMAN) has a Beginning Cash Position of ฿562 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on T.MAN Pharmaceutical PCL and its competitors.
Is T.MAN Pharmaceutical PCL's Beginning Cash Position too high?
T.MAN Pharmaceutical PCL's current Beginning Cash Position is ฿562 Mil. Overall, T.MAN Pharmaceutical PCL has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does T.MAN Pharmaceutical PCL's Beginning Cash Position compare to ZTS and UTHR?
T.MAN Pharmaceutical PCL's Beginning Cash Position of ฿562 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Drug Manufacturers company?
A good Beginning Cash Position depends on the Drug Manufacturers industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on T.MAN Pharmaceutical PCL and its competitors. T.MAN Pharmaceutical PCL's current Beginning Cash Position is ฿562 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is T.MAN Pharmaceutical PCL stock overvalued right now?
T.MAN Pharmaceutical PCL (BKK:TMAN) has a current Beginning Cash Position of ฿562 Mil. The current Beginning Cash Position is ฿562 Mil. T.MAN Pharmaceutical PCL's overall GF Score™ is 18/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For T.MAN Pharmaceutical PCL (BKK:TMAN), the current Beginning Cash Position is ฿562 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

T.MAN Pharmaceutical PCL Business Description

Address Bangkhunthian Road, 69/1 Soi Bangkhunthian 14, Samaedum Subdistrict, Bangkhunthian District, Bangkok, THA, 10150
T.MAN Pharmaceutical PCL is engaged in purchasing, importing, manufacturing, and distributing original equipment and in manufacturing, distributing, and exporting modern medicines, traditional medicines, dietary supplements, and healthcare products for the healthcare industry. It offers products through brands such as T.Nutrition, T.Derma, Mommy&Me, TMT, Heaven Herb, and T.Pharmaceutical. The company's reportable segments are: Segment for manufactured products under own brand, which derives key revenue, Segment for manufactured products under third parties' brand, and Segment for trading products.
18GF Score

Get the complete analysis for BKK:TMAN

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿10.30
Price